Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
Q1 2026 earnings • released • Revenue beat +2.32%
See results
2196:HKG
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
HK$19.11
-2.40%
(-0.47) 1D
Apr 30, 4:08:11 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2196...
Open
HK$19.58
High
HK$19.58
Low
HK$19.03
Mkt. cap
70.24B
Avg. vol.
2.84M
Volume
3.53M
P/E ratio
13.06
52-wk high
HK$29.00
52-wk low
HK$13.44
EPS
HK$1.46
Shares outstanding
551.94M
No. of employees
41K
News stories
From sources across the web
Profile
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International. As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
About Shanghai Fosun Pharmaceutical (Group) Ord Shs H
CEOLiu Yi | Wen Deyong
Employees40.6K
Founded1994
Headquarters-
SectorPharmaceutical industry
Websitefosunpharma.com
Last report
Apr 28, 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ -CNY
Revenue / Estimate
10.07B/ (9.84B est.)CNY
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
10.09B
9.88B
12.27B
10.07B
Cost of goods sold
5.22B
5.08B
5.65B
5.07B
Cost of revenue
5.22B
5.08B
5.65B
5.07B
Research and development expenses
979.21M
1.01B
1.28B
896.79M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.14B
3.10B
4.44B
3.27B
Operating expense
4.19B
4.04B
5.92B
4.19B
Total operating expenses
9.41B
9.12B
11.57B
9.26B
Operating income
685.50M
758.38M
699.05M
813.78M
Other non operating income
-4.87M
-116.85M
107.33M
2.03M
EBT including unusual items
1.37B
1.12B
1.27B
1.36B
EBT excluding unusual items
1.16B
1.49B
1.10B
1.21B
Income tax expense
212.30M
162.98M
82.80M
277.92M
Effective tax rate
15.49%
14.57%
6.50%
20.47%
Other operating expenses
49.69M
-92.19M
117.57M
19.04M
Net income
937.21M
821.33M
847.27M
870.83M
Net profit margin
9.28%
8.31%
6.91%
8.64%
Earnings per share
-
-
-
-
Interest and investment income
925.83M
1.05B
732.13M
689.67M
Interest expense
-323.25M
-321.25M
-291.32M
-296.51M
Net interest expenses
602.58M
727.28M
440.80M
393.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.38B
1.39B
1.47B
1.59B
Gain or loss from assets sale
-2.12M
2.12M
-69.35M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer